bluebird bio Archives -

EMA starts rapid review of Bluebird’s gene therapy for rare disease CALD

https://pharmaphorum.com/news/ema-starts-rapid-review-of-bluebirds-gene-therapy-for-rare-disease-cald/

BMS ‘bet’ with Celgene shareholders in balance after CAR-T refile

https://pharmaphorum.com/news/bms-2/

BMS’ big merger bet is still on with latest CAR-T filing

https://pharmaphorum.com/news/bms-and-bluebird-file-multiple-myeloma-car-t/

LentiGlobin gene therapy for sickle cell on course for filing, says bluebird

https://pharmaphorum.com/news/lentiglobin-gene-therapy-for-sickle-cell-on-course-for-filing-says-bluebird/

FDA approves Global Blood Therapeutics’ sickle cell pill

https://pharmaphorum.com/news/fda-approves-global-blood-therapeutics-sickle-cell-pill/

CAR-TCR Summit Europe

https://pharmaphorum.com/events/car-tcr-summit-europe/

Novo Nordisk builds in haemophilia with Bluebird Bio gene editing deal

https://pharmaphorum.com/news/novo-nordisk-builds-in-haemophilia-with-bluebird-bio-gene-editing-deal/

bluebird presents long-term data from CALD gene therapy

https://pharmaphorum.com/news/bluebird-presents-long-term-data-from-cald-gene-therapy/

bluebird offers instalment payments for Zynteglo gene therapy

https://pharmaphorum.com/news/bluebird-offers-instalment-payments-for-zynteglo-gene-therapy/

Search